Literature DB >> 15265615

Safety evaluation of an alpha-cyclodextrin glycosyltranferase preparation.

A Bär1, C A M Krul, D Jonker, N de Vogel.   

Abstract

Alpha-cyclodextrin glucosyltransferase (alpha-CGTase, EC 2.4.1.19) is an amylolytic enzyme used for the production of alpha-cyclodextrin (alpha-CD), a novel, soluble dietary fiber, from food-grade starch. The safety of an alpha-CGTase preparation obtained by batch fermentation from a recombinant strain of Escherichia coli K12 harboring the alpha-CGTase gene from Klebsiella oxytoca strain M5a1 was examined. In a 13-week subchronic toxicity study in rats, the administration by gavage of the alpha-CGTase preparation at levels of up to 20 ml/kg bw/day, corresponding to a total organic solids dosage of 260 mg/kg bw/day, did not cause any systemic toxic effect. Some signs of irritation were observed in the respiratory tract which occurred, however, in one sex only and/or were not dose-related. Accordingly, these changes were considered to be an unspecific consequence of the reflux and aspiration of the dosing solution. There was no evidence of a genotoxic activity in Ames tests and a chromosome aberration test in cultured human lymphocytes. It is concluded that the examined alpha-CGTase preparation is safe when used for the production of alpha-CD.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265615     DOI: 10.1016/j.yrtph.2004.05.009

Source DB:  PubMed          Journal:  Regul Toxicol Pharmacol        ISSN: 0273-2300            Impact factor:   3.271


  2 in total

1.  Enhanced production of α-cyclodextrin glycosyltransferase in Escherichia coli by systematic codon usage optimization.

Authors:  Hua Liu; Jianghua Li; Guocheng Du; Jingwen Zhou; Jian Chen
Journal:  J Ind Microbiol Biotechnol       Date:  2012-08-17       Impact factor: 3.346

2.  Genetic and rat toxicity studies of cyclodextrin glucanotransferase.

Authors:  Robert R Maronpot; Cheryl A Hobbs; Jeffrey Davis; Carol Swartz; Molly Boyle; Mihoko Koyanagi; Shim-Mo Hayashi
Journal:  Toxicol Rep       Date:  2016-03-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.